Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily A member 6 | 0.861 | 0.231 | 5.1E-27 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
aggrecan | 0.528 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 | 0.890 | 0.077 | 0.92 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2015 | 2015 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 7 | 0.666 | 0.577 | 2.3E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
ADAMTS9 antisense RNA 2 | 0.656 | 0.462 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | |||||||||
|
ADAMTS like 3 | 0.729 | 0.346 | 1.4E-19 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
ArfGAP with dual PH domains 2 | 0.839 | 0.308 | 4.2E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
adhesion G protein-coupled receptor G6 | 0.666 | 0.385 | 6.6E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
apoptosis inducing factor mitochondria associated 3 | 0.861 | 0.192 | 1.9E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
adenylate kinase 9 | 0.751 | 0.346 | 3.7E-26 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
alpha kinase 3 | 0.792 | 0.462 | 8.4E-25 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
archaelysin family metallopeptidase 1 | 0.821 | 0.154 | 3.7E-23 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
anaphase promoting complex subunit 13 | 1.000 | 0.038 | 1.4E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
apolipoprotein O pseudogene 5 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||||
|
Rho GTPase activating protein 15 | 0.682 | 0.462 | 1.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
AT-rich interaction domain 5B | 0.638 | 0.500 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat and SOCS box containing 2 | 0.769 | 0.308 | 6.8E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
ankyrin repeat and SOCS box containing 4 | 0.931 | 0.077 | 1.1E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
activating signal cointegrator 1 complex subunit 3 | 0.861 | 0.231 | 1.2E-20 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
acid sensing ion channel subunit 2 | 0.653 | 0.538 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
asparaginase and isoaspartyl peptidase 1 | 0.494 | 0.808 | 2.8E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
ATP synthase membrane subunit f | 1.000 | 0.115 | 1.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ATP5MF-PTCD1 readthrough | 1.000 | 0.115 | 2.9E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
BBX high mobility group box domain containing | 0.839 | 0.231 | 0.52 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2009 | 2017 |